Clinical trial Recruiting at 2 sites Interventional Ages 60 to 100

Adductor Canal Block and iPACK Pain Control in Total Knee Replacement

Official title: Comparison of the Efficacy and Safety of Three Adjuvant Strategies for ACB and iPACK Blocks in Patients Undergoing Elective Total Knee Arthroplasty: A Prospective, Randomized Clinical Trial

Run by Poznan University of Medical Sciences · NCT07677215 · Data updated 2026-11-12

This trial tests whether adding intravenous dexamethasone, with or without perineural dexmedetomidine, to ACB and iPACK blocks improves pain control and reduces opioid use after knee replacement.

More Knee Osteoarthritis trials

Quick facts

Study typeInterventional
Ages60 Years to 100 Years
SexAll
Enrollment120 (estimated)
SponsorPoznan University of Medical Sciences
Academic / other
Locations2 sites (Lublin and 1 other locations)
StatusRecruiting
StartedMay 20, 2026
Main results expectedSeptember 1, 2027
Study endsOctober 1, 2027
Registry record updatedNovember 5, 2026
Trial IDNCT07677215 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Candidates are adults aged 60–100 years undergoing planned unilateral primary TKA, ASA I–III, eligible for spinal anesthesia and ultrasound-guided blocks.

Probably not a fit

Patients with contraindications to spinal anesthesia, regional blocks, or study drugs, or with conditions that elevate risk for nerve blocks or anesthesia complications, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In adults undergoing elective total knee arthroplasty, the study compares three analgesia strategies using ultrasound-guided ACB and iPACK blocks with 0.2% ropivacaine: standard blocks, blocks plus intravenous dexamethasone, and blocks with intravenous dexamethasone plus perineural dexmedetomidine. All patients receive spinal anesthesia and ropivacaine for blocks. The primary outcome is total opioid consumption in the first 48 hours postoperatively; secondary outcomes include pain scores, duration of analgesia, time to first rescue analgesia, and quadriceps strength. The trial aims to optimize postoperative analgesia while supporting early mobilization and reducing opioid-related side effects. The investigation builds on prior evidence that dexamethasone and dexmedetomidine can prolong analgesia, exploring their combined effects in this regional anesthesia approach.

Why it matters

Potential benefit: If successful, the approach could provide longer-lasting pain relief and lower opioid needs after knee replacement.

How similar studies have gone: Previous studies suggest dexamethasone and dexmedetomidine can enhance regional block analgesia, but optimal combinations for ACB/iPACK in TKA require more evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 60 and 100 years
* Scheduled for elective primary unilateral total knee arthroplasty
* American Society of Anesthesiologists (ASA) physical status I-III
* Ability to understand study procedures and provide written informed consent
* Eligibility for spinal anesthesia and ultrasound-guided regional anesthesia according to institutional standards

Exclusion Criteria:

* Known allergy or hypersensitivity to ropivacaine, dexamethasone, dexmedetomidine, or any study-related medication
* Contraindications to spinal anesthesia or peripheral nerve blocks
* Coagulation disorders or anticoagulant therapy preventing safe regional anesthesia
* Infection at the planned puncture site or systemic infection
* Severe neurological disorders affecting lower limb sensory or motor function
* Severe hepatic, renal, or uncontrolled cardiovascular disease
* Clinically significant bradycardia or advanced atrioventricular conduction abnormalities
* Chronic opioid use for more than 3 months before surgery
* Uncontrolled diabetes mellitus or contraindications to dexamethasone administration
* Inability or refusal to provide written informed consent

Where it's running

  • The John Paul II Catholic University of Lublin
    Lublin, Poland
    Recruiting
  • Poznan University of Medical Sciences
    Poznan, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.